2024-09-25 |
2024-09-23 |
B
Purchase
|
ROSENWALD LINDSAY A MD
PRESIDENT, CEO & CHAIRMAN
Executive Director
Large shareholder
|
763,359
+26.4%
1.84
USD 1,404,581
|
763,359
+26.4%
|
1.84
|
USD 1,404,581
|
|
2024-07-15 |
2024-07-11 |
B
Purchase
|
ROSENWALD LINDSAY A MD
President, CEO & Chairman
Executive Director
Large shareholder
|
5,000
+4.1%
7.48
USD 37,418
|
5,000
+4.1%
|
7.48
|
USD 37,418
|
|
2024-07-12 |
2024-07-10 |
B
Purchase
|
Jin David
Chief Financial Officer
Officer
|
500
+inf%
7.50
USD 3,750
|
500
+inf%
|
7.50
|
USD 3,750
|
|
2024-07-11 |
2024-07-09 |
B
Purchase
|
ROSENWALD LINDSAY A MD
President, CEO & Chairman
Executive Director
Large shareholder
|
5,000
+4.3%
7.39
USD 36,971
|
5,000
+4.3%
|
7.39
|
USD 36,971
|
|
2024-07-10 |
2024-07-08 |
B
Purchase
|
ROSENWALD LINDSAY A MD
President, CEO & Chairman
Executive Director
Large shareholder
|
5,000
+4.4%
7.35
USD 36,765
|
5,000
+4.4%
|
7.35
|
USD 36,765
|
|
2024-07-01 |
2024-06-28 |
B
Purchase
|
ROSENWALD LINDSAY A MD
President, CEO & Chairman
Executive Director
Large shareholder
|
20,000
+0.7%
1.64
USD 32,724
|
20,000
+0.7%
|
1.64
|
USD 32,724
|
|
2024-05-20 |
2024-05-20 |
S
Sale
|
Klein Dov
Non-Executive Director
|
10,000
-15.8%
1.89
USD 18,900
|
10,000
-15.8%
|
1.89
|
USD 18,900
|
|
2024-05-20 |
2024-05-16 |
B
Purchase
|
ROSENWALD LINDSAY A MD
President, CEO & Chairman
Executive Director
Large shareholder
|
10,000
+0.3%
1.76
USD 17,589
|
10,000
+0.3%
|
1.76
|
USD 17,589
|
|
2024-05-20 |
2024-05-16 |
B
Purchase
|
ROSENWALD LINDSAY A MD
President, CEO & Chairman
Executive Director
Large shareholder
|
10,000
+0.3%
1.76
USD 17,589
|
10,000
+0.3%
|
1.76
|
USD 17,589
|
|
2024-01-09 |
2024-01-05 |
B
Purchase
|
ROSENWALD LINDSAY A MD
President, CEO & Chairman
Executive Director
Large shareholder
|
50,000
+1.8%
2.38
USD 118,770
|
50,000
+1.8%
|
2.38
|
USD 118,770
|
|
2023-11-16 |
2023-11-14 |
B
Purchase
|
WEISS MICHAEL S
See Remarks
Executive Director
|
147,058
+15.0%
1.70
USD 249,999
|
147,058
+15.0%
|
1.70
|
USD 249,999
|
|
2023-11-16 |
2023-11-14 |
B
Purchase
|
ROSENWALD LINDSAY A MD
President, CEO & Chairman
Executive Director
Large shareholder
|
1,567,515
+152.2%
1.70
USD 2,664,776
|
1,567,515
+152.2%
|
1.70
|
USD 2,664,776
|
|
2023-09-27 |
2023-09-26 |
B
Purchase
|
ROSENWALD LINDSAY A MD
President, CEO & Chairman
Executive Director
Large shareholder
|
100,000
+0.7%
0.28
USD 28,330
|
100,000
+0.7%
|
0.28
|
USD 28,330
|
|
2023-08-21 |
2023-08-18 |
B
Purchase
|
ROSENWALD LINDSAY A MD
President, CEO & Chairman
Executive Director
Large shareholder
|
10,000
+9.8%
9.34
USD 93,400
|
10,000
+9.8%
|
9.34
|
USD 93,400
|
|
2023-08-21 |
2023-08-17 |
B
Purchase
|
ROSENWALD LINDSAY A MD
President, CEO & Chairman
Executive Director
Large shareholder
|
10,000
+10.8%
11.75
USD 117,500
|
10,000
+10.8%
|
11.75
|
USD 117,500
|
|
2023-02-14 |
2023-02-10 |
B
Purchase
|
ROSENWALD LINDSAY A MD
President, CEO & Chairman
Executive Director
Large shareholder
|
2,395,209
+18.5%
0.84
USD 2,000,000
|
2,395,209
+18.5%
|
0.84
|
USD 2,000,000
|
|
2023-02-14 |
2023-02-10 |
B
Purchase
|
Rowinsky Eric K
Non-Executive Director
|
11,976
+1.3%
0.84
USD 10,000
|
11,976
+1.3%
|
0.84
|
USD 10,000
|
|
2023-02-14 |
2023-02-10 |
B
Purchase
|
LOBELL J JAY
Non-Executive Director
|
299,401
+22.4%
0.84
USD 250,000
|
299,401
+22.4%
|
0.84
|
USD 250,000
|
|
2023-02-14 |
2023-02-10 |
B
Purchase
|
Lu Lucy
Non-Executive Director
|
11,976
+9.9%
0.84
USD 10,000
|
11,976
+9.9%
|
0.84
|
USD 10,000
|
|
2023-02-14 |
2023-02-10 |
B
Purchase
|
Jin David
Chief Financial Officer
Officer
|
35,928
+2.6%
0.84
USD 30,000
|
35,928
+2.6%
|
0.84
|
USD 30,000
|
|
2023-02-14 |
2023-02-10 |
B
Purchase
|
WEISS MICHAEL S
See Remarks
Executive Director
Large shareholder
|
1,197,604
+8.8%
0.84
USD 999,999
|
1,197,604
+8.8%
|
0.84
|
USD 999,999
|
|
2022-12-05 |
2022-12-01 |
B
Purchase
|
ROSENWALD LINDSAY A MD
PRESIDENT, CEO & CHAIRMAN
Executive Director
Large shareholder
|
100,000
+0.9%
0.68
USD 67,960
|
100,000
+0.9%
|
0.68
|
USD 67,960
|
|
2022-12-02 |
2022-11-30 |
PP
Planned purchase
|
Jin David
Chief Financial Officer
Officer
|
5,000
+0.4%
0.56
USD 2,800
|
5,000
+0.4%
|
0.56
|
USD 2,800
|
|
2022-12-02 |
2022-11-30 |
PP
Planned purchase
|
ROSENWALD LINDSAY A MD
PRESIDENT, CEO & CHAIRMAN
Executive Director
Large shareholder
|
5,000
+0.0%
0.56
USD 2,800
|
5,000
+0.0%
|
0.56
|
USD 2,800
|
|
2022-10-24 |
2022-10-21 |
B
Purchase
|
ROSENWALD LINDSAY A MD
PRESIDENT, CEO & CHAIRMAN
Executive Director
Large shareholder
|
100,000
+0.9%
0.70
USD 69,500
|
100,000
+0.9%
|
0.70
|
USD 69,500
|
|
2022-04-29 |
2021-12-28 |
S
Sale
|
Klein Dov
Non-Executive Director
|
5,000
-0.8%
2.45
USD 12,250
|
5,000
-0.8%
|
2.45
|
USD 12,250
|
|
2022-04-29 |
2021-09-21 |
S
Sale
|
Hunter Robyn
Chief Financial Officer
Officer
|
28,292
-14.7%
3.13
USD 88,554
|
28,292
-14.7%
|
3.13
|
USD 88,554
|
|
2021-04-09 |
2021-03-02 |
S
Sale
|
Rowinsky Eric K
Non-Executive Director
|
10,000
-1.4%
4.45
USD 44,500
|
10,000
-1.4%
|
4.45
|
USD 44,500
|
|
2021-04-09 |
2021-02-19 |
S
Sale
|
Rowinsky Eric K
Non-Executive Director
|
8,000
-1.1%
4.31
USD 34,480
|
8,000
-1.1%
|
4.31
|
USD 34,480
|
|
2021-04-09 |
2021-02-18 |
S
Sale
|
Rowinsky Eric K
Non-Executive Director
|
6,000
-0.8%
4.20
USD 25,200
|
6,000
-0.8%
|
4.20
|
USD 25,200
|
|
2021-04-09 |
2021-02-16 |
S
Sale
|
Rowinsky Eric K
Non-Executive Director
|
2,000
-0.3%
3.86
USD 7,720
|
2,000
-0.3%
|
3.86
|
USD 7,720
|
|
2021-04-09 |
2021-02-05 |
S
Sale
|
Rowinsky Eric K
Non-Executive Director
|
4,000
-0.5%
3.80
USD 15,200
|
4,000
-0.5%
|
3.80
|
USD 15,200
|
|
2021-04-09 |
2021-01-01 |
B
Purchase
|
Lorenz Kevin
Non-Executive Director
|
50,000
0.00
USD 0
|
50,000
|
0.00
|
USD 0
|
|
2020-09-25 |
2020-09-22 |
S
Sale
|
Hunter Robyn
Chief Financial Officer
Officer
|
28,450
-12.9%
4.38
USD 124,611
|
28,450
-12.9%
|
4.38
|
USD 124,611
|
|
2020-09-01 |
2020-08-26 |
B
Purchase
|
ROSENWALD LINDSAY A MD
PRESIDENT, CEO & CHAIRMAN
Executive Director
Large shareholder
|
52,500
+131.2%
18.00
USD 945,000
|
52,500
+131.2%
|
18.00
|
USD 945,000
|
|
2020-09-01 |
2020-08-26 |
B
Purchase
|
Hoenlein Malcolm
Non-Executive Director
|
16,667
+inf%
18.00
USD 300,006
|
16,667
+inf%
|
18.00
|
USD 300,006
|
|
2020-03-13 |
2020-01-01 |
B
Purchase
|
Lorenz Kevin
|
50,000
0.00
USD 0
|
50,000
|
0.00
|
USD 0
|
|
2020-03-13 |
2019-12-01 |
PP
Planned purchase
|
ROSENWALD LINDSAY A MD
PRESIDENT, CEO & CHAIRMAN
Executive Director
Large shareholder
|
1,123
+0.0%
2.06
USD 2,313
|
1,123
+0.0%
|
2.06
|
USD 2,313
|
|
2020-03-13 |
2019-06-03 |
PP
Planned purchase
|
ROSENWALD LINDSAY A MD
PRESIDENT, CEO & CHAIRMAN
Executive Director
Large shareholder
|
1,467
+0.0%
1.10
USD 1,614
|
1,467
+0.0%
|
1.10
|
USD 1,614
|
|
2019-12-31 |
2019-06-03 |
PP
Planned purchase
|
Hunter Robyn
Chief Financial Officer
Officer
|
2,297
+1.1%
1.10
USD 2,527
|
2,297
+1.1%
|
1.10
|
USD 2,527
|
|
2018-12-13 |
2018-12-11 |
S
Sale
|
Avgerinos George
SVP, BIOLOGICS OPERATIONS
Officer
|
97,325
-27.6%
1.05
USD 102,191
|
97,325
-27.6%
|
1.05
|
USD 102,191
|
|
2018-11-30 |
2018-11-23 |
S
Sale
|
Hunter Robyn
Chief Financial Officer
Officer
|
20,370
-7.8%
1.29
USD 26,277
|
20,370
-7.8%
|
1.29
|
USD 26,277
|
|
2017-12-18 |
2017-12-14 |
S
Sale
|
Avgerinos George
SVP, BIOLOGICS OPERATIONS
|
12,000
-3.3%
3.55
USD 42,600
|
12,000
-3.3%
|
3.55
|
USD 42,600
|
|
2017-12-14 |
2017-12-13 |
S
Sale
|
Avgerinos George
SVP, BIOLOGICS OPERATIONS
|
19,000
-5.0%
3.57
USD 67,830
|
19,000
-5.0%
|
3.57
|
USD 67,830
|
|
2017-12-14 |
2017-12-12 |
S
Sale
|
Avgerinos George
SVP, BIOLOGICS OPERATIONS
|
25,593
-6.3%
3.59
USD 91,879
|
25,593
-6.3%
|
3.59
|
USD 91,879
|
|
2017-11-08 |
2017-11-06 |
B
Purchase
|
ROSENWALD LINDSAY A MD
PRESIDENT, CEO
Executive Director
Large shareholder
|
40,000
+inf%
25.00
USD 1,000,000
|
40,000
+inf%
|
25.00
|
USD 1,000,000
|
|
2017-01-27 |
2016-12-01 |
PP
Planned purchase
|
ROSENWALD LINDSAY A MD
President and CEO
Executive Director
Large shareholder
|
731
+0.0%
2.03
USD 1,484
|
731
+0.0%
|
2.03
|
USD 1,484
|
|
2016-09-19 |
2016-09-16 |
S
Sale
|
Avgerinos George
SVP, Biologics Operations
Officer
|
33,912
-11.6%
2.55
USD 86,476
|
33,912
-11.6%
|
2.55
|
USD 86,476
|
|
2016-09-19 |
2016-09-15 |
S
Sale
|
Avgerinos George
SVP, Biologics Operations
Officer
|
15,000
-4.9%
2.54
USD 38,100
|
15,000
-4.9%
|
2.54
|
USD 38,100
|
|
2016-06-17 |
2016-06-01 |
PP
Planned purchase
|
ROSENWALD LINDSAY A MD
President and CEO
Executive Director
Large shareholder
|
613
+0.0%
2.40
USD 1,471
|
613
+0.0%
|
2.40
|
USD 1,471
|
|
2014-11-10 |
2014-11-06 |
B
Purchase
|
ROSENWALD LINDSAY A MD
President and CEO
Executive Director
Large shareholder
|
150,000
+3.2%
1.61
USD 241,500
|
150,000
+3.2%
|
1.61
|
USD 241,500
|
|
2014-11-10 |
2014-11-06 |
B
Purchase
|
Hoenlein Malcolm
Non-Executive Director
|
25,000
+83.3%
1.61
USD 40,250
|
25,000
+83.3%
|
1.61
|
USD 40,250
|
|
2014-11-10 |
2014-11-06 |
B
Purchase
|
WEISS MICHAEL S
Exec. VC - Strategic Dev.
Executive Director
Large shareholder
|
1,000,000
+16.8%
1.61
USD 1,610,000
|
1,000,000
+16.8%
|
1.61
|
USD 1,610,000
|
|
2014-04-23 |
2014-04-22 |
S
Sale
|
HORGAN KEVIN
Former Chief Medical Officer
|
47,566
-100.0%
1.89
USD 89,976
|
47,566
-100.0%
|
1.89
|
USD 89,976
|
|
2014-04-22 |
2014-04-21 |
S
Sale
|
HORGAN KEVIN
Former Chief Medical Officer
|
19,000
-100.0%
1.81
USD 34,382
|
19,000
-100.0%
|
1.81
|
USD 34,382
|
|
2014-04-21 |
2014-04-17 |
S
Sale
|
HORGAN KEVIN
Former Chief Medical Officer
|
101
-100.0%
1.85
USD 187
|
101
-100.0%
|
1.85
|
USD 187
|
|
2013-08-22 |
2013-08-21 |
B
Purchase
|
LOBELL J JAY
Non-Executive Director
|
5,000
+1.5%
7.37
USD 36,850
|
5,000
+1.5%
|
7.37
|
USD 36,850
|
|
2013-08-22 |
2013-08-21 |
B
Purchase
|
Lu Lucy
Chief Financial Officer
Officer
|
5,000
+25.6%
7.38
USD 36,900
|
5,000
+25.6%
|
7.38
|
USD 36,900
|
|
2013-07-18 |
2013-07-17 |
B
Purchase
|
Lu Lucy
Chief Financial Officer
Officer
|
4,545
+30.3%
7.90
USD 35,906
|
4,545
+30.3%
|
7.90
|
USD 35,906
|
|
2013-06-21 |
2013-06-20 |
B
Purchase
|
LOBELL J JAY
Non-Executive Director
|
10,000
+3.1%
7.62
USD 76,231
|
10,000
+3.1%
|
7.62
|
USD 76,231
|
|
2013-06-21 |
2013-06-20 |
B
Purchase
|
Weisman Harlan F
Chairman and CEO
Executive Director
|
10,000
+50.0%
7.59
USD 75,900
|
10,000
+50.0%
|
7.59
|
USD 75,900
|
|
2013-01-15 |
2013-01-14 |
B
Purchase
|
Weisman Harlan F
Chairman and CEO
Executive Director
|
20,000
+inf%
5.71
USD 114,200
|
20,000
+inf%
|
5.71
|
USD 114,200
|
|
2012-06-26 |
2012-06-22 |
B
Purchase
|
LOBELL J JAY
Non-Executive Director
|
25,000
+8.4%
5.00
USD 125,000
|
25,000
+8.4%
|
5.00
|
USD 125,000
|
|
2012-06-26 |
2012-06-22 |
B
Purchase
|
Lu Lucy
Chief Financial Officer
Officer
|
10,000
+inf%
5.00
USD 50,000
|
10,000
+inf%
|
5.00
|
USD 50,000
|
|
2012-06-26 |
2012-06-22 |
B
Purchase
|
RITTER DALE
SVP & Chief Accounting Officer
Officer
|
5,000
+100.0%
5.00
USD 25,000
|
5,000
+100.0%
|
5.00
|
USD 25,000
|
|
2012-06-26 |
2012-06-22 |
B
Purchase
|
SANDAGE BOBBY W PHD
President and CEO
Executive Director
|
10,000
+87.0%
5.00
USD 50,000
|
10,000
+87.0%
|
5.00
|
USD 50,000
|
|
2012-06-26 |
2012-06-22 |
B
Purchase
|
COOPER GLENN L MD
See Remarks
Executive Director
|
10,000
+33.3%
5.30
USD 52,968
|
10,000
+33.3%
|
5.30
|
USD 52,968
|
|
2012-06-26 |
2012-06-22 |
B
Purchase
|
ROSENWALD LINDSAY A MD
Non-Executive Director
Large shareholder
|
200,000
+8.1%
5.00
USD 1,000,000
|
200,000
+8.1%
|
5.00
|
USD 1,000,000
|
|
2012-06-26 |
2012-06-22 |
B
Purchase
|
Hehenberger Karin M.
See Remarks
Officer
|
20,000
+2162.2%
5.00
USD 100,000
|
20,000
+2162.2%
|
5.00
|
USD 100,000
|
|
2012-06-26 |
2012-06-22 |
B
Purchase
|
Beerman Noah D
EVP & COO
Officer
|
5,000
+100.0%
5.00
USD 25,000
|
5,000
+100.0%
|
5.00
|
USD 25,000
|
|
2012-01-23 |
2012-01-23 |
B
Purchase
|
ROSENWALD LINDSAY A MD
Non-Executive Director
Large shareholder
|
2,000
+0.1%
6.95
USD 13,900
|
2,000
+0.1%
|
6.95
|
USD 13,900
|
|
2012-01-20 |
2012-01-20 |
B
Purchase
|
ROSENWALD LINDSAY A MD
Non-Executive Director
Large shareholder
|
2,000
+0.1%
5.66
USD 11,320
|
2,000
+0.1%
|
5.66
|
USD 11,320
|
|
2012-01-19 |
2012-01-19 |
B
Purchase
|
ROSENWALD LINDSAY A MD
Non-Executive Director
Large shareholder
|
2,000
+0.1%
5.67
USD 11,340
|
2,000
+0.1%
|
5.67
|
USD 11,340
|
|
2012-01-18 |
2012-01-18 |
B
Purchase
|
ROSENWALD LINDSAY A MD
Non-Executive Director
Large shareholder
|
2,000
+0.1%
5.66
USD 11,320
|
2,000
+0.1%
|
5.66
|
USD 11,320
|
|
2012-01-17 |
2012-01-17 |
B
Purchase
|
ROSENWALD LINDSAY A MD
Non-Executive Director
Large shareholder
|
2,000
+0.1%
5.40
USD 10,800
|
2,000
+0.1%
|
5.40
|
USD 10,800
|
|